GGrantIndex
Sort

46,585 grants matching heart failure

Roles for endoplasmic reticulum associated degradation (ERAD) in Myocardial Proteostasis

$723,894
Christopher C Glembotski · University Of Arizona · R01 · FY2024 · HL

Depression and Heart Failure Disease Progression

$723,872
Andrew Sherwood · Duke University · R01 · FY2015 · HL

General Capillary to Arterial Endothelial Cell Transition in Pulmonary ArterialHypertension

$723,817
Zhiyu Dai · Washington University · R01 · FY2025 · HL

Ceramides in Diastolic Heart Failure

$723,742
William L Holland · University Of Utah · R01 · FY2024 · HL

A RCT to Reduce Cardiopulmonary Rehospitalizations

$723,735
Brian W Jack · Boston Medical Center · R01 · FY2007 · HL

Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart

$723,674
Daniel Patrick Kelly · University Of Pennsylvania · R01 · FY2022 · HL

A 3D IN VITRO DISEASE MODEL OF ATRIAL CONDUCTION

$723,616
Steven Carl George · University Of California At Davis · UH3 · FY2020 · HL

International Consortium for Multimodality Phenotyping in Adults with Non-compaction

$723,528
Koen Nieman · Stanford University · R01 · FY2022 · HL

Antithrombotic Therapy with No Bleeding Risk for PCI

$723,518
Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2019 · HL

Anti-inflammatory therapy to augment CFTR rescue in CF patients

$723,464
Matthias A Salathe · University Of Miami School Of Medicine · R01 · FY2017 · HL

Quantitative coronary flow capacity with low-dose CT for ischemia but no obstructive coronary artery disease

$723,396
Sabee Y Molloi · University Of California-Irvine · R01 · FY2024 · HL

Research Resource for Complex Physiologic Signals

$723,328
Ary L Goldberger · Beth Israel Deaconess Medical Center · U01 · FY2009 · EB

Epidemiologic Determinant of Cardiac Structure and Function Among Hispanics

$723,227
Carlos Jose Rodriguez · Wake Forest University Health Sciences · R01 · FY2011 · HL

Pathophysiology of Myocardial Disease

$723,208
David Alan Kass · Johns Hopkins University · T32 · FY2015 · HL

Prospective Monitoring of Newly Approved Cardiovascular Drugs in Older Adults with Frailty

$723,192
Dae Hyun Kim · Brigham And Women'S Hospital · R01 · FY2021 · AG

Project 3: Perception of Tobacco Use in Vulnerable Populations

$723,171
Herman Alfred Taylor · American Heart Association · P50 · FY2013 · HL

Targeting Interleukin-17 inflammatory Axis in CTEPH

$723,084
Yen-Rei Andrea Yu · University Of Colorado Denver · R01 · FY2025 · HL

TREATMENT OF FUNCTIONAL IMPAIRMENT IN PATIENTS WITH HEART FAILURE AND COMORBID DE

$723,069
Kenneth E Freedland · Washington University · R01 · FY2009 · HL

Plasticity of nTS output neurons in acute and chronic hypoxia

$723,032
Eileen M Hasser · University Of Missouri-Columbia · R01 · FY2010 · HL

Mesenchymal stem cell enhancement of organ allograft repair and long term surviva

$722,952
Amelia M. Bartholomew · University Of Miami School Of Medicine · P01 · FY2014 · AI

The Look AHEAD Continuation: Action for Health in Diabetes

$722,846
Helen Pauline Hazuda · University Of Texas Hlth Science Center · U01 · FY2010 · DK

Structure function relationships from deep mutational scanning in human cardiomyopathy

$722,799
Euan A Ashley · Stanford University · R01 · FY2020 · HL

Targeting Abnormal Calcium Cycling Using Novel Gene Therapy Vectors

$722,797
Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · HL

Risk Alleles in Protein Quality Control Genes as Modifiers of Hypertrophic Cardiomyopathy

$722,735
Sharlene M Day · University Of Pennsylvania · R01 · FY2025 · HL

ECMO without Anticoagulation

$722,686
Alvaro Rojas-Pena · University Of Michigan At Ann Arbor · R01 · FY2024 · HL